The World Health Organization said Monday that it will temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.
U.N. COVID-19 Therapy Trial Pauses Hydroxychloroquine Testing Due to Report of Higher Death Risk
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over